Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 27, 2021

View Archived Issues

VY-NPC101, a potential NPC1-based gene therapy strategy for Niemann-Pick disease type C

Discovery of novel VMAT2 inhibitor with potential for the treatment of tardive dyskinesia

New tyrosine-protein kinase CSK inhibitors identified at Plexxikon

Stealth BioTherapeutics describes compounds for treating mitochondrial disease

Global Blood Therapeutics patents pyruvate kinase activators

Vertex Pharmaceuticals discovers alpha-1-antitrypsin (Z-mutant) polymerization inhibitors

New TYK2 inhibitors synthesized at Eternity Bioscience

Ec1-LoPE DARPin-toxin fusion protein evaluated with trastuzumab for ovarian cancer

188Re-Rituximab shows promise for treating CD20-overexpressing cancers

Vyne reports findings with BET inhibitor VYN-201 in animal model and ex vivo human tissue study

CRISP/Cas9 modulation of utrophin as a strategy to treat DMD

Diverse Biotech's DBT-12733 shows efficacy against glioblastoma tumor cells

New mouse model shows possibility of reversing autosomal dominant polycystic kidney disease

Study casts light on DNA damage in esophageal cancer

Novel split-intein-based gene therapy strategy to treat Wilson disease

mLB-001 GeneRide vector restores hepatocyte function in MMA mice

RFN-ALFQ nanoparticle vaccine elicits immunity against SARS-CoV-2 in macaques

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...